文献速递主动脉疾病

近端固定型主动脉腔内装置或与腹主动脉瘤修复后肾功能下降无关

Proximal fixation of endovascular aortic device may not be associated with renal function decline after abdominal aortic aneurysm repair.
PubMed 文献 · J Vasc Surg · 2021-06-26

本研究回顾性分析了2000至2018年间在三站点医疗系统内进行的1130例择期EVAR,比较肾上固定(SuF)与肾下固定(InF)装置对肾功能的影响。结果显示两组长期肌酐和eGFR变化无统计学差异,但SuF组住院时间更长,且合并慢性肾病的SuF患者进展至血透的风险更高。

要点

  • 肾上与肾下固定装置在长期随访中对肌酐和eGFR变化无显著影响。
  • SuF装置与住院时间延长独立相关,女性及术中出血>150 mL也是预测因素。
  • 合并慢性肾病的SuF患者进展至血透的风险更高,需谨慎选择。

核心结论

  • 装置固定类型不影响择期EVAR后长期肌酐和eGFR变化,但SuF与住院时间延长及慢性肾病患者血透进展风险相关。

研究设计与样本

  • 回顾性综述,纳入2000至2018年三站点医疗系统内1130例择期EVAR,SuF组670例(59.3%),InF组460例(40.7%),长期随访4.8±3.7年。

主要发现

  • 两组长期肌酐和eGFR变化率无统计学差异。
  • SuF组住院时间更长(3.4±2.2 vs 2.3±1.0天;P < .001)。
  • 多因素回归显示女性(Coef, 2.4; 95%CI, 0.17-0.41; P = .02)、SuF(Coef, 9.5; 95%CI, 0.11-1.11; P < .0001)和术中出血>150 mL(Coef, 15.4; 95%CI, 0.11-1.76; P < .0001)是住院时间延长的预测因素。

临床怎么用

  • 对于肾功能正常的患者,SuF与InF装置对长期肾功能影响相似,但SuF可能延长住院时间。
  • 对已有肾功能不全的患者,选择SuF装置需谨慎评估血透进展风险。

局限性

  • 回顾性单机构三站点研究,可能存在选择偏倚和未测量混杂。
  • 长期随访中肾功能变化数据可能不完整。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Significant debate exists among providers who perform endovascular abdominal aortic aneurysm repair (EVAR) regarding the renal function change between suprarenal (SuF) and infrarenal (InF) fixation devices. The purpose of this study is to review our institution's experience using these devices in terms of renal function. METHODS: This is a retrospective review of all elective EVARs performed within a three-site health system (Florida, Minnesota, and Arizona) during the period of 2000 to 2018. The primary outcome was renal function decline on long-term follow-up depending on the anatomical fixation of the device (SuF vs InF). Secondary outcomes were length of hospitalization (LOH) and progression to hemodialysis. Multivariable regression analysis was performed to test for associations affecting LOH. RESULTS: There were 1130 elective EVARs included in our review. Of those, 670 (59.3%) had SuF and 460 (40.7%) InF. Long-term follow-up was 4.8 ± 3.7 years, and the rate of change in creatinine and estimated glomerular filtration rate (eGFR) were not statistically significant among groups (SuF vs InF). LOH was higher in those individuals with a SuF device (3.4 ± 2.2 vs 2.3 ± 1.0 days; P < .001). Ten patients with chronic kidney disease progressed to hemodialysis at 6.7 ± 3.8 years from EVAR. On Kaplan-Meier analysis, patients with chronic kidney disease with SuF were more likely to progress to hemodialysis (P = .039). On multivariable regression, female sex (Coef, 2.4; 95% confidence interval [CI], 0.17-0.41; P = .02), SuF (Coef, 9.5; 95% CI, 0.11-1.11; P < .0001), and intraoperative blood loss of greater than 150 mL (Coef, 15.4; 95% CI, 0.11-1.76; P < .0001) were predictors of prolonged LOH. CONCLUSIONS: Our three-site, single-institution data indicate that, although the starting eGFR was statistically lower in those individuals undergoing elective EVAR with InF, device fixation type did not affect the creatinine and eGFR on long-term follow-up. However, caution should be exercised at the time of abdominal aortic aneurysm repair in those individuals who already presented with renal dysfunction.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Erben Y, Li Y, Mao MA, et al. Proximal fixation of endovascular aortic device may not be associated with renal function decline after abdominal aortic aneurysm repair. J Vasc Surg. 2021. PMID: 34182031. doi:10.1016/j.jvs.2021.05.050

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。